Media

Business Television – Algernon Pharmaceuticals and the DMT/Stroke Clinical Program
Streetwise Live! – Algernon is Awaiting Approval for a Phase 1 DMT Human Stroke Study
Proactive Investors Interview – Algernon Pharmaceuticals Discloses Novel Salt Patent Strategy for DMT Intellectual Property
Share via
Copy link
Powered by Social Snap